Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB11 | O95342 | 2/20 | 0.88 |
| ▸ | HTT | P42858 | 2/20 | 0.88 |
| ▸ | GSDMD | P57764 | 2/20 | 0.88 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.88 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.88 |
| ▸ | CA12 | O43570 | 5/20 | 0.46 |
| ▸ | CA1 | P00915 | 5/20 | 0.46 |
| ▸ | CA2 | P00918 | 5/20 | 0.46 |
| ▸ | CA9 | Q16790 | 5/20 | 0.46 |
| ▸ | EHMT2 | Q96KQ7 | 3/20 | 0.46 |
| ▸ | EHMT1 | Q9H9B1 | 3/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | MGLL | Q99685 | 4/20 | 0.43 |
| ▸ | PHGDH | O43175 | 3/20 | 0.43 |
| ▸ | ALDH2 | P05091 | 3/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ditiocarb SCHEMBL1395953 | 0.97 | ABCB11 (0.94) | ABCB11HTTGSDMDCYP2E1PTGS1 | |
| Ditiocarb SCHEMBL622679 | 0.97 | — | — | |
| Ditiocarb SCHEMBL3134487 | 0.97 | — | — | |
| Ditiocarb SCHEMBL27713779 | 0.94 | ABCB11 (0.88) | ABCB11HTTGSDMDCYP2E1PTGS1 | |
| Ditiocarb SCHEMBL6802052 | 0.94 | ABCB11 (0.88) | ABCB11HTTGSDMDCYP2E1PTGS1 | |
| Ditiocarb SCHEMBL28246801 | 0.94 | ABCB11 (0.88) | ABCB11HTTGSDMDCYP2E1PTGS1 | |
| Ditiocarb SCHEMBL18221923 | 0.94 | ABCB11 (0.88) | ABCB11HTTGSDMDCYP2E1PTGS1 | |
| Ditiocarb SCHEMBL5836899 | 0.94 | ABCB11 (0.88) | ABCB11HTTGSDMDCYP2E1PTGS1 | |
| Ditiocarb SCHEMBL30777192 | 0.94 | ABCB11 (1.00) | ABCB11HTTGSDMDCYP2E1PTGS1 | |
| Ditiocarb SCHEMBL48382 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11007273-B2 | Prochelators as targeted prodrugs for prostate cancer and methods of making and using same | DUKE UNIVERSITY (US) | 2021-05-18 | — | — | US | disclosed |
| US-20200171160-A1 | PROCHELATORS AS TARGETED PRODRUGS FOR PROSTATE CANCER AND METHODS OF MAKING AND USING SAME | DUKE UNIVERSITY | 2020-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11007273-B2 | Prochelators as targeted prodrugs for prostate cancer and methods of making and using same | FOLH1, FAP, BPHL | ABCB11 2692/4885HTT 4414/4885GSDMD 1646/4885 |
| US-20200171160-A1 | PROCHELATORS AS TARGETED PRODRUGS FOR PROSTATE CANCER AND METHODS OF MAKING AND USING SAME | FOLH1, FAP, BPHL | ABCB11 2692/4885HTT 4414/4885GSDMD 1646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.